RxDoctor Payments Data

Hasan Syed, MD

Orthopaedic Surgery · Loma Linda, CANPI 1982816468

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (53.1%), travel and lodging and education — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Zimmer Biomet at 32.5% of the total. 2025 is the largest year on record at $586, 2.2 times the $272 reported in 2019. That places this record below the midpoint for orthopaedic surgery clinicians in CA, where the typical reported total is $2,444.

$1,630in general payments, 2019–2025

Across 25 payments — averaging $65.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Zimmer Biomet$529
  • Stryker$453
  • Moximed, Inc$181
  • Smith+Nephew$179
  • Sportstek Medical, Inc$117
  • Sanofi-aventis U.S. LLC$109
  • plus $63 from 3 others
$6,743in research payments, 2019–2025

Across 5 payments — averaging $1348.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Smith+Nephew$7K

What the payments were for

  • Travel & lodging$42926%
  • Food & beverage$86653%
  • Education$33621%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Zimmer Biomet7$529
Stryker4$453
Moximed, Inc3$181
Smith+Nephew6$179
Sportstek Medical, Inc1$117
Sanofi-aventis U.S. LLC1$109
Novo Nordisk1$23
Johnson & Johnson1$21
Hydrocision, Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,630 in reported general payments places this provider in the 40th percentile of 1,808 orthopaedic surgery providers in California.

See all orthopaedic surgery providers in California →

Medicare billing

Part B allowed, 2024
$42,202
Medicare patients
88
Services billed
331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ibuprofen57$364
Diclofenac Sodium24$316
Gabapentin32$278
Ondansetron Hcl30$164
Omeprazole38$156
Baclofen16$145
Methylprednisolone12$78
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen12$71
Cephalexin22$61
Tramadol Hcl24$61
Oxycodone Hcl20$57
Meloxicam39$47

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Loma Linda

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →